ArticleJournal of inflammation research2026

Methodological Considerations on the Optimal Duration of Dual Antiplatelet Therapy in Patients with High Residual Inflammatory Risk [Letter].

Tianrui Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.